Transforming Pharmaceutical Research

MIT AI Models Fast-Track New Drug Discovery

Researchers at the Coley Lab deploy FlowER and ShEPhERD to identify drug candidates using generative AI.

By Kronos Digital News Desk··1 min read
A digital visualization of a complex molecular structure and chemical reaction pathways on a high-resolution laboratory monitor, representing MIT's new generative AI drug discovery models.

A digital visualization of a complex molecular structure and chemical reaction pathways on a high-resolution laboratory monitor, representing MIT's new generative AI drug discovery models.

Photo: Kronos Digital News

Researchers at the Massachusetts Institute of Technology developed AI tools to speed up medicine development. The Coley Lab at MIT released computational models called FlowER and ShEPhERD [1]. These systems analyze millions of chemical compounds to predict reaction pathways and evaluate how drugs interact with proteins [1].

Pharmaceutical companies are already using these tools to find small-molecule drug candidates [1]. Traditional experimental methods take much longer than these new digital simulations [1]. By applying chemical principles to generative AI, the team aims to make drug discovery more efficient [1].

Editorial notes

Transparency note

AI assisted drafting. Human edited and reviewed.

AI assisted
Yes
Human review
Yes
Last updated

Risk assessment

High

The story relies on a single source domain (MIT News), failing the requirement for three independent domains.

Sources

Related stories

View all

Topics

Get the weekly briefing

A concise briefing with selected stories and analysis.

No spam. Unsubscribe anytime. By joining, you agree to our Privacy Policy.

About the author

Kronos Digital News Desk covers transforming pharmaceutical research and editorial analysis for Kronos Digital News.